West Pharmaceutical Services, Inc’s recently made public that its VP & Treasurer Witherspoon Charles unloaded Company’s shares for reported $0.22 million on Oct 29 ’24. In the deal valued at $310.40 per share,703 shares were sold. As a result of this transaction, Witherspoon Charles now holds 1,253 shares worth roughly $0.28 million.
Then, Witherspoon Charles sold 1,029 shares, generating $308,700 in total proceeds. Upon selling the shares at $300.00, the VP & Treasurer now owns 1,478 shares.
Before that, Hofmann Thomas W sold 617 shares. West Pharmaceutical Services, Inc shares valued at $225,773 were divested by the Director at a price of $365.92 per share. As a result of the transaction, Hofmann Thomas W now holds 43,565 shares, worth roughly $9.83 million.
Deutsche Bank upgraded its West Pharmaceutical Services, Inc [WST] rating to a Buy from a a Hold in a research note published recently. A number of analysts have revised their coverage, including Citigroup’s analysts, who began to cover the stock in early January with a ‘”a Buy”‘ rating. Wolfe Research began covering WST with “Peer perform” recommendation on December 13, 2024. UBS revised its rating on December 12, 2024. It rated WST as “a Buy” which previously was an “a Neutral”.
Price Performance Review of WST
On Tuesday, West Pharmaceutical Services, Inc [NYSE:WST] saw its stock fall -1.09% to $225.56. Over the last five days, the stock has gained 2.46%. West Pharmaceutical Services, Inc shares have fallen nearly -31.14% since the year began. Nevertheless, the stocks have fallen -37.06% over the past one year. While a 52-week high of $400.88 was reached on 01/28/25, a 52-week low of $197.01 was recorded on 02/13/25. SMA at 50 days reached $303.37, while 200 days put it at $310.97.
Levels Of Support And Resistance For WST Stock
The 24-hour chart illustrates a support level at 221.90, which if violated will result in even more drops to 218.25. On the upside, there is a resistance level at 229.12. A further resistance level may holdings at 232.69. The Relative Strength Index (RSI) on the 14-day chart is 32.61, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 4.82, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bearish at 77.58%. Stochastics %K at 24.73% indicates the stock is a holding.
